簡介

本頁面提供了有關 Pascal Deschatelets 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Pascal Deschatelets已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:APLS / Apellis Pharmaceuticals, Inc. Chief Scientific Officer 0
如何解讀這些圖表

以下圖表顯示了在Pascal Deschatelets進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Pascal Deschatelets 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -25,840 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -11,284 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -3,372 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -4,909 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -25,840 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 25,840 25,840
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -12,920 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 12,920 12,920
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -10,030 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 10,030 10,030
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -41,250 0 -100.00
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 41,250 41,250
2026-05-14 2026-05-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
U - Other -1,177,222 0 -100.00
2026-01-30 2026-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 25,840 1,177,222 2.24
2026-01-23 2026-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -5,928 1,151,382 -0.51 21.77 -129,025 25,060,290
2026-01-21 2026-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -909 1,157,310 -0.08 19.79 -17,992 22,906,521
2026-01-15 2026-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2,277 1,158,219 -0.20 22.19 -50,520 25,697,637
2025-05-22 2025-05-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 12,780 1,160,496 1.11 3.76 48,053 4,363,465
2025-01-30 2025-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -826 1,147,716 -0.07 29.52 -24,386 33,884,708
2025-01-23 2025-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3,948 1,148,542 -0.34 30.43 -120,120 34,944,965
2025-01-21 2025-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 15,045 1,152,490 1.32
2025-01-21 2025-01-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -750 1,137,445 -0.07 29.96 -22,469 34,075,805
2025-01-14 2025-01-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -2,288 1,138,195 -0.20 28.70 -65,670 32,668,587
2024-05-21 2024-05-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 24,500 1,140,483 2.20 3.76 92,120 4,288,216
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,115,983 -0.01 44.02 -4,402 49,131,152
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -22,472 1,116,083 -1.97 42.85 -962,903 47,823,040
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -56,335 1,138,555 -4.71 42.15 -2,374,543 47,990,549
2024-05-09 2024-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 78,907 1,194,890 7.07 4.31 340,089 5,149,976
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,728 1,115,983 -0.42 54.92 -259,639 61,284,430
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -64,379 1,120,711 -5.43 54.12 -3,483,966 60,648,957
2024-04-09 2024-04-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 69,107 1,185,090 6.19 3.76 259,842 4,455,938
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 1,115,983 -0.01 63.35 -6,335 70,697,523
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -26,257 1,116,083 -2.30 62.69 -1,646,041 69,966,797
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -42,750 1,142,340 -3.61 61.88 -2,645,173 70,682,744
2024-03-11 2024-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 69,107 1,185,090 6.19 3.67 253,623 4,349,280
2024-02-13 2024-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -1,148 1,115,983 -0.10 67.77 -77,796 75,626,708
2024-01-31 2024-01-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -874 1,117,131 -0.08 64.14 -56,057 71,650,772
2024-01-23 2024-01-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -3,913 1,118,005 -0.35 65.00 -254,329 72,665,853
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -1,632 1,121,918 -0.15 66.81 -109,032 74,953,771
2024-01-17 2024-01-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 6,743 1,123,550 0.60
2023-11-15 2023-11-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 45,000 1,116,807 4.20 3.76 169,200 4,199,194
2023-11-09 2023-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,071,807 -1.11 47.27 -567,240 50,664,317
2023-11-09 2023-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 17,494 1,083,807 1.64 2.67 46,709 2,893,765
2023-10-10 2023-10-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,066,313 -1.11 40.38 -484,560 43,057,719
2023-10-10 2023-10-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,078,313 1.75 2.67 49,395 2,879,096
2023-09-11 2023-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -12,000 1,059,813 -1.12 42.87 -514,440 45,434,183
2023-09-11 2023-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,071,813 1.76 2.67 49,395 2,861,741
2023-08-09 2023-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,053,313 -1.13 23.66 -283,920 24,921,386
2023-08-09 2023-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,065,313 1.77 2.67 49,395 2,844,386
2023-07-11 2023-07-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,046,813 -1.13 84.55 -1,014,600 88,508,039
2023-07-11 2023-07-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,058,813 1.78 2.67 49,395 2,827,031
2023-06-09 2023-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,040,313 -1.14 91.35 -1,096,200 95,032,593
2023-06-09 2023-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,052,313 1.79 2.67 49,395 2,809,676
2023-05-09 2023-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,033,813 -1.15 92.39 -1,108,680 95,513,983
2023-05-09 2023-05-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,045,813 1.80 2.67 49,395 2,792,321
2023-04-11 2023-04-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,027,313 -1.15 78.21 -938,520 80,346,150
2023-04-11 2023-04-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,039,313 1.81 2.67 49,395 2,774,966
2023-03-10 2023-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,020,813 -1.16 63.79 -765,480 65,117,661
2023-03-10 2023-03-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,032,813 1.82 2.67 49,395 2,757,611
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,195 1,014,313 -0.12 58.50 -69,908 59,337,310
2023-02-22 2023-02-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 9,886 1,015,508 0.98
2023-02-14 2023-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,134 1,005,622 -0.11 51.21 -58,072 51,497,903
2023-02-10 2023-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 1,006,756 -1.18 54.45 -653,400 54,817,864
2023-02-10 2023-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 1,018,756 1.85 2.67 49,395 2,720,079
2023-01-30 2023-01-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -832 1,000,256 -0.08 52.77 -43,905 52,783,509
2023-01-24 2023-01-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -2,326 1,001,088 -0.23 52.05 -121,068 52,106,630
2023-01-17 2023-01-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 19,634 1,003,414 2.00
2023-01-10 2023-01-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 983,780 -1.21 46.08 -552,960 45,332,582
2023-01-10 2023-01-09 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 995,780 1.89 2.67 49,395 2,658,733
2022-12-30 2022-12-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 7,000 977,280 0.72 3.67 25,690 3,586,618
2022-12-12 2022-12-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 970,280 -1.22 47.50 -570,000 46,088,300
2022-12-12 2022-12-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 982,280 1.92 2.67 49,395 2,622,688
2022-11-10 2022-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 963,780 -1.23 46.47 -557,640 44,786,857
2022-11-10 2022-11-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 975,780 1.93 2.67 49,395 2,605,333
2022-10-11 2022-10-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 957,280 -1.24 57.50 -690,000 55,043,600
2022-10-11 2022-10-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 969,280 1.95 2.67 49,395 2,587,978
2022-09-12 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 950,780 -1.25 63.98 -767,760 60,830,904
2022-09-12 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 962,780 1.96 2.67 49,395 2,570,623
2022-08-09 2022-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 944,280 -1.25 62.50 -750,000 59,017,500
2022-08-09 2022-08-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 18,500 956,280 1.97 2.67 49,395 2,553,268
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 937,780 -1.26 47.95 -575,400 44,966,551
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,500 949,780 0.69 2.67 17,355 2,535,913
2022-07-12 2022-07-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 12,000 943,280 1.29 2.67 32,040 2,518,558
2022-06-22 2022-06-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 33,005 931,280 3.67 2.67 88,123 2,486,518
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,500 898,275 0.73 2.67 17,355 2,398,394
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -12,000 891,775 -1.33 44.09 -529,080 39,318,360
2022-06-09 2022-06-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 12,000 903,775 1.35 2.67 32,040 2,413,079
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -4,000 364,999 -1.08
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -4,000 891,775 -0.45 44.43 -177,720 39,621,563
2022-05-02 2022-04-29 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 4,000 895,775 0.45 2.67 10,680 2,391,719
2022-05-02 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
J - Other -11,250 0 -100.00
2022-05-02 2022-04-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other -1,875 891,775 -0.21
2022-02-14 2022-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -1,057 893,650 -0.12 47.12 -49,806 42,108,788
2022-02-01 2022-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -931 894,707 -0.10 38.59 -35,927 34,526,743
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 36,951 36,951
2022-01-25 2022-01-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 26,051 895,638 3.00
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 368,999 -1.67
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 869,587 -0.71 65.61 -410,062 57,053,603
2021-06-25 2021-06-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 875,837 0.72 2.67 16,688 2,338,485
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 375,249 -1.64
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 869,587 -0.71 47.40 -296,250 41,218,424
2021-05-25 2021-05-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 875,837 0.72 2.67 16,688 2,338,485
2021-04-29 2021-04-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -4,500 381,499 -1.17
2021-04-29 2021-04-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 4,500 869,587 0.52 2.67 12,015 2,321,797
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,250 385,999 -1.59
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -6,250 865,087 -0.72 46.13 -288,312 39,906,463
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise X 6,250 871,337 0.72 2.67 16,688 2,326,470
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6,250 392,249 -1.57
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -6,250 865,087 -0.72 50.74 -317,125 43,894,514
2021-03-11 2021-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 6,250 871,337 0.72 2.67 16,688 2,326,470
2021-02-11 2021-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
F - Taxes -688 865,087 -0.08 47.72 -32,831 41,281,952
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 11,250 11,250
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 45,000 45,000
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 1,875 865,775 0.22
2021-02-01 2021-01-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 7,500 863,900 0.88
2020-03-12 2020-03-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
G - Gift -161,656 847,025 -16.03
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -117,205 0 -100.00
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -55,398 1,008,681 -5.21 40.98 -2,270,155 41,334,739
2020-02-14 2020-02-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 117,205 1,064,079 12.38 2.14 250,819 2,277,129
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise X -117,206 117,205 -50.00
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale -52,075 946,874 -5.21 42.80 -2,228,966 40,529,048
2020-02-14 2020-02-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
M - Exercise 117,206 998,949 13.29 2.14 250,821 2,137,751
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 56,250 56,250
2020-02-12 2020-02-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
A - Award 9,375 891,118 1.06
2019-09-26 2019-09-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,010 881,743 -0.11 25.64 -25,897 22,608,772
2019-09-26 2019-09-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,531 882,753 -2.27 25.24 -518,161 22,278,920
2019-09-25 2019-09-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -1,295 903,284 -0.14 24.96 -32,321 22,544,162
2019-09-25 2019-09-24 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,307 904,579 -2.20 24.56 -498,760 22,217,365
2019-09-25 2019-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 924,886 -0.01 25.53 -2,553 23,612,340
2019-09-25 2019-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
S - Sale X -20,758 924,986 -2.19 25.07 -520,362 23,187,549
2019-02-12 2019-02-08 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy)
A - Award 95,000 95,000
2018-05-09 2018-05-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock
J - Other 384,292 945,744 68.45
2018-02-21 2018-02-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 110,000 110,000
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
1,122,904
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock
1,122,904
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)